First-Trimester Placental Growth Factor in Screening for Gestational Diabetes.

Mosimann, Beatrice; Amylidi, Sofia Kalypso; Risch, Lorenz; Wiedemann, Ute; Surbek, Daniel; Baumann, Marc Ulrich; Stettler, Christoph; Raio, Luigi (2015). First-Trimester Placental Growth Factor in Screening for Gestational Diabetes. Fetal diagnosis and therapy, 39(4), pp. 287-291. Karger 10.1159/000441027

Preview

Text 441027.pdf - Published Version Available under License Publisher holds Copyright. Download (135kB) | Preview

OBJECTIVE

The aim of this study was first to assess whether first-trimester serum concentrations of placental growth factor (PlGF) differ between patients with and without gestational diabetes (GDM) and second to test whether there is a correlation between glycosylated hemoglobin (HbA1c), a factor recently shown to be useful in predicting GDM, and PlGF.

METHODS

PlGF was measured at 8-14 weeks with the Kryptor Immunoassay Analyzer (Brahms, Berlin, Germany). Absolute values were converted to multiples of the median using the software provided by the Fetal Medicine Foundation London. GDM was diagnosed using internationally accepted criteria. HbA1c levels were quantified using the TOSOH G7 automated hemoglobin analyzer.

RESULTS

From January to December 2014, 328 women were included in the study, 51 (15.5%) of whom developed GDM. First-trimester PlGF quantification does not discriminate between women at risk to develop GDM and controls, while HbA1c is able to do so. No correlation was found between PlGF and HbA1c.

CONCLUSION

Our findings do not lend support to the hypothesis that early PlGF values are different in women who later develop GDM.

Interest & Impact

Downloads

476 since deposited on 04 Mar 2016
52 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item